Satoshi Yasukochi

Dr. Satoshi Yasukochi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
MNMasaki Nii
Masaki Nii
RIRyo Inuzuka
Ryo Inuzuka
KIKei Inai
Kei Inai
ESEriko Shimada
Eriko Shimada
TSTokuko Shinohara
Tokuko Shinohara
Toshio NakanishiToshio Nakanishi
Toshio Nakanishi

1 January 2014 in Circulation Journal
Verified
Journal Article
Open access
TSTsugutoshi Suzuki
Tsugutoshi Suzuki
NSNaokata Sumitomo
Naokata Sumitomo
JYJun Yoshimoto
Jun Yoshimoto
AMAya Miyazaki
Aya Miyazaki
KHKazuhiro Hinokiyama
Kazuhiro Hinokiyama
SYSatoshi Yasukochi
Satoshi Yasukochi
In Japan, the use of implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy with a biventricular pacemaker (CRTP) and CRT with a defibrillator (CRTD) in children has not been studied statistically, and dual-chamber (DDD) pacemakers are still used for pediatric CRT because of current government regulations. Data were obtained from 15 children's and 74 general hospitals through a questionnaire survey regarding the aforementioned therapies performed before 2012 in Japanese children (<16 years old). ICD, CRT with DDD, CRTP and CRTD were used in 64 (42%), 47 (31%), 34 (22%) and 7 (5%), respectively, of all cases reported (n=152). Among all CRTP and CRT-DDD cases (n=81), the use of DDD accounted for 41% in general hospitals vs. 89% in children's hospitals, and CRT-DDD and CRTP were effective in 67 cases (83%). Of 64 ICD cases, appropriate shocks were experienced in 28 cases (44%), and inappropriate shocks in 19 cases (29%). Additionally, data from the Japan Arrhythmia Device Industry Association obtained for overall device usage analysis revealed that CRTP was more commonly used in children than in adults. There is an increasing need for pediatric device therapy, especially CRTP. However, many children's hospitals were still using DDD pacemakers in 2012. Although the demand for device therapy in children may be small, it is indispensable in pediatric cardiology.

Verified
Journal Article
Open access
PDF file
Isao ShiraishiIsao Shiraishi
Isao Shiraishi
MYMasaaki Yamagishi
Masaaki Yamagishi
THTakaya Hoashi
Takaya Hoashi
YKYoshiaki Kato
Yoshiaki Kato
SIShigemitsu Iwai
Shigemitsu Iwai
KKKenichi Kurosaki
Kenichi Kurosaki
Three-dimensional (3D) printing is an advanced technology for accurately understanding anatomy and supporting the successful surgical management of complex congenital heart disease (CHD). We aimed to evaluate whether our super-flexible 3D heart models could facilitate preoperative decision-making and surgical simulation for complex CHD. The super-flexible heart models were fabricated by stereolithography 3D printing of the internal and external contours of the heart from cardiac computed tomography (CT) data, followed by vacuum casting with a polyurethane material similar in elasticity to a child’s heart. Nineteen pediatric patients with complex CHD were enrolled (median age, 10 months). The primary endpoint was defined as the percentage of patients rated as “essential” on the surgeons’ postoperative 5-point Likert scale. The accuracy of the models was validated by a non-destructive method using industrial CT. The super-flexible heart models allowed detailed anatomical diagnosis and simulated surgery with incisions and sutures. Thirteen patients (68.4%) were classified as “essential” by the primary surgeons after surgery, with a 95% confidence interval of 43.4–87.4%, meeting the primary endpoint. The product error within 90% of the total external and internal surfaces was 0.54 ± 0.21 mm. The super-flexible 3D heart models are accurate, reliable, and useful tools to assist surgeons in decision-making and allow for preoperative simulation in CHD.

30 October 2024 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
YAYohei Akazawa
Yohei Akazawa
SYSatoshi Yasukochi
Satoshi Yasukochi
KTKohta Takei
Kohta Takei
KTKiyohiro Takigiku
Kiyohiro Takigiku
NINoboru Inamura
Noboru Inamura
FGFetal HQ Study Group
Fetal HQ Study Group

1 May 2019 in Pediatric Cardiology and Cardiac Surgery
Verified
Journal Article
Open access
PDF file
NYNaoki Yoshimura
Naoki Yoshimura
MYMasaaki Yamagishi
Masaaki Yamagishi
TSTakaaki Suzuki
Takaaki Suzuki
HIHajime Ichikawa
Hajime Ichikawa
SYSatoshi Yasukochi
Satoshi Yasukochi
KSKisaburo Sakamoto
Kisaburo Sakamoto
背景:日本小児循環器学会では外科系教育部会を設置し,次世代小児心臓外科医育成プロジェクトを立ち上げることとなった.方法:今回,プロジェクトの一環として我が国の小児心臓外科医の労働環境,修練状況等に関する情報を得るために,日本小児循環器学会の外科系会員を対象にアンケート調査を行った.2018年6月26日(火)~8月6日(火)の期間に,日本小児循環器学会正会員の心臓血管外科医師420名に対し匿名式によるWEBアンケートを依頼し,176名から回答が得られた(回答率42%).結果:小児心臓外科医の15%が月10回以上の当直を行っており,実に85%が法定労働時間の上限を超えていた.また,今回のアンケート結果から,小児心臓外科医の修練環境は「施設によって大きなばらつきがある」ということが確認された.外科医ひとりあたりの手術症例数にもばらつきが生じてしまい,十分な数の執刀経験が得られているとは言いがたく,過酷な労働環境も相まって,多くの外科医が不満と不安を抱えているのが現状であった.結語:「執刀症例の数や難易度等ある程度プログラム化された修練環境」,「出身大学や所属する医局に左右されない修練施設の運用」,「過酷な労働環境の改善」が必要であり,「オールジャパンで次世代を育てる」というシステムを構築していく必要がある.

10 March 2021 in Circulation Reports
Verified
Journal Article
Open access
PDF file
TMTakekazu Miyoshi
Takekazu Miyoshi
AKAtsuko Kato
Atsuko Kato
SYSatoshi Yasukochi
Satoshi Yasukochi
STSara Takahashi
Sara Takahashi
MHMami Ho
Mami Ho
TKTohru Kobayashi
Tohru Kobayashi
Background:In Japan, the choice of pediatric medical devices is limited because of 2 “device lag” problems: Japan lags behind the USA and Europe in device development, and development of pediatric devices lags behind that of adult devices. We aimed to identify the problems with and impediments to pediatric medical device development as recognized by pediatric physicians in Japan.Methods and Results:A voluntary survey of pediatric medical devices for all council members of the Japanese Society of Pediatric Cardiology and Cardiac Surgery was conducted in 2019. The response rate was 47.1% (154/327). The respondents were 115 pediatric cardiologists (74.7%) and 39 cardiovascular surgeons (25.3%). Approximately 90% believed that difficulties in development existed. Approximately 70% were dissatisfied with the pediatric medical devices currently available in Japan, which was a result of the unavailability of medical devices approved overseas, few types and sizes, and off-label use. Factors that hindered the development of pediatric medical devices included anatomical issues specific to children with congenital heart disease, as well as system issues such as lack of corporate profitability, development cost, and amount of time for development.Conclusions:Pediatric cardiologists and cardiovascular surgeons regard “device lag” and “off-label use” in Japan as important hindrances to the delivery of better medical care for pediatric patients with congenital heart disease.